Malgorzata Stawicka
Overview
Explore the profile of Malgorzata Stawicka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
544
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tomiczek-Szwiec J, Szwiec M, Falco M, Cybulski C, Wokolorczyk D, Jakubowska A, et al.
Br J Cancer
. 2022 Mar;
127(1):84-91.
PMID: 35256754
Background: To estimate the impact of oophorectomy and other treatments on the survival of breast cancer patients with a CHEK2 mutation. Methods: Women with Stage I-III breast cancer who were...
2.
Kluzniak W, Wokolorczyk D, Rusak B, Huzarski T, Kashyap A, Stempa K, et al.
Cancers (Basel)
. 2019 Oct;
11(10).
PMID: 31614901
Bloom Syndrome is a rare recessive disease which includes a susceptibility to various cancers. It is caused by homozygous mutations of the gene. To investigate whether heterozygous carriers of a...
3.
Gronwald J, Lubinski J, Huzarski T, Cybulski C, Menkiszak J, Siolek M, et al.
Gynecol Oncol
. 2019 Sep;
155(2):270-274.
PMID: 31500890
Objective: To compare the survival experience of women with a BRCA1 mutation who enrolled in an ovarian cancer screening program with that of women who opted for preventive oophorectomy. Methods:...
4.
Cybulski C, Kluzniak W, Huzarski T, Wokolorczyk D, Kashyap A, Rusak B, et al.
Int J Cancer
. 2019 Jun;
145(12):3311-3320.
PMID: 31173646
To optimize genetic testing, it is necessary to establish the spectrum of breast cancer-predisposing mutations in particular ethnic groups. We studied 1,018 women with a strong family history for breast...
5.
Antczak A, Wokolorczyk D, Kluzniak W, Kashyap A, Jakubowska A, Gronwald J, et al.
Eur J Cancer Prev
. 2014 Sep;
24(2):122-7.
PMID: 25187206
A number of single nucleotide polymorphisms (SNPs) in the human genome have been associated with increased risk of prostate cancer. Recently, a single SNP in the region of chromosome 8q24...
6.
Antczak A, Kluzniak W, Wokolorczyk D, Kashyap A, Jakubowska A, Gronwald J, et al.
Gene
. 2013 Oct;
532(2):173-6.
PMID: 24096176
Background: Germline mutations of BRCA2 and NBS1 genes cause inherited recessive chromosomal instability syndromes and predispose to prostate cancer of poor prognosis. Mutations of the BLM gene cause another chromosomal...
7.
Huzarski T, Byrski T, Gronwald J, Gorski B, Domagala P, Cybulski C, et al.
J Clin Oncol
. 2013 Aug;
31(26):3191-6.
PMID: 23940229
Purpose: To estimate 10-year overall survival (OS) rates for patients with early-onset breast cancer, with and without a BRCA1 mutation, and to identify prognostic factors among those with BRCA1-positive breast...
8.
Kotsopoulos J, Sukiennicki G, Muszynska M, Gackowski D, Kaklewski K, Durda K, et al.
Cancer Causes Control
. 2012 May;
23(7):1065-74.
PMID: 22576580
Purpose: Few studies have evaluated the role of micronutrients or trace elements in breast cancer development among BRCA1 mutation carriers. To investigate a possible role of dietary and environmental exposures...
9.
Lubinski J, Huzarski T, Byrski T, Lynch H, Cybulski C, Ghadirian P, et al.
Int J Cancer
. 2011 Aug;
131(1):229-34.
PMID: 21834074
Women with a BRCA1 mutation face a high lifetime risk of breast cancer. It is unknown to what extent environmental factors modify the inherent genetic risk. If women from different...
10.
Byrski T, Gronwald J, Huzarski T, Grzybowska E, Budryk M, Stawicka M, et al.
J Clin Oncol
. 2009 Dec;
28(3):375-9.
PMID: 20008645
Purpose: To estimate the rate of pathologic complete response (pCR) to neoadjuvant chemotherapy in BRCA1 mutation carriers according to chemotherapy regimen. Patients And Methods: From a registry of 6,903 patients,...